BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 29052137)

  • 1. Malignancies in HIV-Infected and AIDS Patients.
    Ji Y; Lu H
    Adv Exp Med Biol; 2017; 1018():167-179. PubMed ID: 29052137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer in women living with HIV.
    D'Andrea F; Ceccarelli M; Facciolà A; Nunnari G; Pellicanò GF; Venanzi Rullo E
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1158-1164. PubMed ID: 30779085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in Malignancies among Korean Patients Infected with Human Immunodeficiency Virus in the Highly Active Antiretroviral Therapy Era.
    Lee S; Lee SH; Lee JE; Kang JS; Lee SG; Chung JS; Kwak IS
    J Korean Med Sci; 2017 Sep; 32(9):1445-1450. PubMed ID: 28776339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of AIDS-defining cancers and virus-related and non-virus-related non-AIDS-defining cancers among HIV-infected patients compared with the general population in a large health district of Northern Italy, 1999-2009.
    Calabresi A; Ferraresi A; Festa A; Scarcella C; Donato F; Vassallo F; Limina R; Castelli F; Quiros-Roldan E;
    HIV Med; 2013 Sep; 14(8):481-90. PubMed ID: 23560682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Epidemiology of HIV-associated malignancies].
    Launay O; Guillevin L
    Bull Cancer; 2003 May; 90(5):387-92. PubMed ID: 12850760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer risk in people infected with human immunodeficiency virus in the United States.
    Engels EA; Biggar RJ; Hall HI; Cross H; Crutchfield A; Finch JL; Grigg R; Hylton T; Pawlish KS; McNeel TS; Goedert JJ
    Int J Cancer; 2008 Jul; 123(1):187-94. PubMed ID: 18435450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The epidemiology of acquired immunodeficiency syndrome malignancies.
    Goedert JJ
    Semin Oncol; 2000 Aug; 27(4):390-401. PubMed ID: 10950365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opportunistic malignancies and the acquired immunodeficiency syndrome.
    Mueller N; Hatzakis A
    Princess Takamatsu Symp; 1987; 18():159-71. PubMed ID: 3506539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.
    Clifford GM; Polesel J; Rickenbach M; Dal Maso L; Keiser O; Kofler A; Rapiti E; Levi F; Jundt G; Fisch T; Bordoni A; De Weck D; Franceschi S;
    J Natl Cancer Inst; 2005 Mar; 97(6):425-32. PubMed ID: 15770006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AIDS malignancies in the era of highly active antiretroviral therapy.
    Gates AE; Kaplan LD
    Oncology (Williston Park); 2002 Apr; 16(4):441-51, 456, 459. PubMed ID: 12017534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in the incidence of AIDS-defining and non-AIDS-defining cancers in people living with AIDS: a population-based study from São Paulo, Brazil.
    Tanaka LF; Latorre MDRD; Gutierrez EB; Heumann C; Herbinger KH; Froeschl G
    Int J STD AIDS; 2017 Oct; 28(12):1190-1198. PubMed ID: 28178892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spectrum of AIDS defining & non-AIDS defining malignancies in north India.
    Sachdeva RK; Sharma A; Singh S; Varma S
    Indian J Med Res; 2016 May; 143(Supplement):S129-S135. PubMed ID: 27748287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoplasms-associated deaths in HIV-1 infected and non-infected patients in Bahia, Brazil.
    Marques M; Luz E; Leal M; Oliveira JV; Patrício R; Netto EM; Brites C
    Cancer Epidemiol; 2018 Jun; 54():133-136. PubMed ID: 29727806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Malignancy cases in HIV-positive patients in Lodz region in years 1992-2010].
    Jabłonowska E; Małolepsza E; Strycharz M; Wójcik K
    Przegl Epidemiol; 2011; 65(2):339-43. PubMed ID: 21913486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignant tumors and AIDS.
    Nasti G; Vaccher E; Errante D; Tirelli U
    Biomed Pharmacother; 1997; 51(6-7):243-51. PubMed ID: 9309244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AIDS-related malignancies: emerging challenges in the era of highly active antiretroviral therapy.
    Cheung MC; Pantanowitz L; Dezube BJ
    Oncologist; 2005; 10(6):412-26. PubMed ID: 15967835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AIDS-related cancer and severity of immunosuppression in persons with AIDS.
    Biggar RJ; Chaturvedi AK; Goedert JJ; Engels EA;
    J Natl Cancer Inst; 2007 Jun; 99(12):962-72. PubMed ID: 17565153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of highly active antiretroviral therapy on the incidence and outcomes of AIDS-defining cancers in Southern Alberta.
    Gingues S; Gill MJ
    HIV Med; 2006 Sep; 7(6):369-77. PubMed ID: 16903981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [AIDS associated cancers in the era of highly active antiretroviral therapy (HAART)].
    Tserenpuntsag B; Kołacińska A; Jabłonowska E
    Przegl Epidemiol; 2007; 61(3):529-34. PubMed ID: 18069390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human immunodeficiency virus/acquired immunodeficiency syndrome and cancer: past, present, and future.
    Engels EA; Goedert JJ
    J Natl Cancer Inst; 2005 Mar; 97(6):407-9. PubMed ID: 15769998
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 22.